SELLAS Life Sciences Group, Inc. (SLS) Price
SELLAS Life Sciences Group, Inc.
SLS
Données du marché non disponibles.
Volume (24 h)
--
Offre en circulation
--
Capitalisation boursière
--
À propos du SELLAS Life Sciences Group, Inc. (SLS)
À propos du SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.
Télécharger le
Application mobile Gemini
Parrainez vos amis, gagnez des cryptomonnaies.
Invitez vos amis sur Gemini et gagnez tous les deux 50 $ en cryptomonnaie votre filleul tradent 100 $ au cours des 30 premiers jours.
Jetons populaires
Jetons populaires
Gemini ActiveTrader®
Trader SELLAS Life Sciences Group, Inc. sur la plateforme conçue et développée pour les traders
Jetons populaires
Jetons populaires
À propos du SELLAS Life Sciences Group, Inc. (SLS)
À propos du SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.